<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36115" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Pregnancy Contractions</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McEvoy</surname>
            <given-names>Austin</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sabir</surname>
            <given-names>Sarah</given-names>
          </name>
          <aff>Rawalpindi Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Austin McEvoy declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarah Sabir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36115.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The uterus is a hollow organ that provides protective and nutritive support to the ovum from the moment it is fertilized until it grows into a well-developed fetus ready for parturition. Its middle muscular layer is called the myometrium, which is known for its rhythmic contractions which result in 'endometrial waves' in the nonpregnant uterus, Braxton Hicks contractions during pregnancy, and true labor towards the end of the third trimester. Labor contractions are painful, regular, and present with a change in cervical dilation and/or effacement.</p>
      </sec>
      <sec id="article-36115.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Since uterine contractions are always present in a thriving uterus, they are differentiated based on frequency, amplitude, duration, and direction of propagation. Although there have been recent advances in knowledge regarding uterine contractions, there remains a huge gap in understanding the related physiology at the cellular and molecular levels. Knowledge of the process of uterine contractions that eventually leads to the expulsion of the baby helps clinicians identify abnormalities that may lead to obstetrical complications, such as preterm labor and arrest of labor. This also aids the pharmacists in developing and improving the drugs used for labor augmentation, induction, and tocolysis (see <bold>Image.&#x000a0;</bold>Medications Used to Manage Abnormal Labor).&#x000a0;Uterine contractions also play an essential role in minimizing postpartum bleeding, which explains why many drugs used to treat this complication target the pathway involved in myometrial contractility.&#x000a0;</p>
      </sec>
      <sec id="article-36115.s3" sec-type="Cellular Level&#x0000d;&#x0000a;">
        <title>Cellular Level
</title>
        <p>Uterine myocytes are smooth muscle cells packed heavily with myofilaments, dense bodies, and dense bands. These cells have more actin than myosin by a factor of 6. The dense bodies attach actin filaments, ensuring the contraction results in a force along the longitudinal direction of the myocyte.&#x000a0;The actin filaments of the contractile machinery&#x000a0;are attached to the cytoskeleton&#x000a0;with the help of&#x000a0;dense bands. This transmits the forces from the contractile units toward the plasma membrane, leading to a shortening of the myocyte.</p>
        <p>The myosin present in these cells is classified as MII. It is a hexamer molecule of&#x000a0;2 myosin heavy chains (MHC) and&#x000a0;2 pairs of myosin light chains (MLC). It forms&#x000a0;3 basic domains. The &#x02018;head&#x02019; region comprises the globular N-terminal end of the MHCs that protrudes laterally from the filament. It has&#x000a0;the actin-binding region and the ATP hydrolysis site that gives the energy needed for contraction. This is converted into a larger movement due to the stiff 'neck' domain at the C-terminal end of the motor region.<xref ref-type="bibr" rid="article-36115.r1">[1]</xref>&#x000a0;The 'neck' domain is also where myosin light chains bind non-covalently. The &#x02018;tail&#x02019; domain comprises the C-terminal ends of the myosin-heavy chains, which are intertwined in an &#x003b1;-helical rod and form the major constituents of the thick filaments of the myocytes.</p>
        <p>Intermediate filaments present in myocytes give shape to the cell and help signal transduction and spatiotemporal organization of the cell, augmenting the tension created by the contractile action.&#x000a0;The cells communicate with one another through connections called gap junctions which increase towards the end of pregnancy to help in synchronous contractions. As the uterus hypertrophies, the amount of actin and myosin in myocytes increases in pregnancy. Phosphocreatine, glycogen, and fatty acid deposits are increased to provide energy for contractions. The blood flow to the uterus during the pregnancy rises in sync with the growing&#x000a0;need for perfusion but later lags towards the end of pregnancy.</p>
      </sec>
      <sec id="article-36115.s4" sec-type="Development">
        <title>Development</title>
        <p>The myometrium has&#x000a0;2 layers. The circular layer is thinner and present at the innermost aspect of muscle fibers and is derived from the paramesonephric/Mullerian ducts. It is called sub-endometrial or junctional endometrium. The outer longitudinal layer comprises intertwined muscle bundles embedded in an extracellular matrix of highly vascular collagen fibers. This helps build the intense pressure needed for contractions. The longitudinal layer originates from non-Mullerian tissue.&#x000a0;Both layers work together to expel the fetus from the uterine cavity. Some studies have suggested that myometrial cells exhibit "pacemaker" capabilities, such as those in the gut and urethra, that facilitate synchronous uterine contractions, although the evidence for this is inconsistent.<xref ref-type="bibr" rid="article-36115.r2">[2]</xref></p>
      </sec>
      <sec id="article-36115.s5" sec-type="Function">
        <title>Function</title>
        <p>The primary function of uterine contractions is to expel the fetus from the uterine cavity. However, contractions also play an essential role in minimizing postpartum hemorrhage. Knowing the normal physiology of uterine contractions also allows clinicians to better differentiate between the true onset of labor and prodromal labor, also known as Braxton Hicks contractions.&#x000a0;Braxton Hicks contractions occur sporadically and do not increase in strength. They&#x000a0;are irregular in duration, frequency, and intensity, are unpredictable and non-rhythmic, and are more uncomfortable than painful. True labor consists of contractions at regular intervals. As labor progresses, these contractions&#x000a0;become stronger, and the time between each contraction decreases. The first stage of labor is divided into&#x000a0;2 phases, defined by the degree of cervical dilation. The latent phase is during the dilation from 0 to 6 cm, while the active phase starts from 6 cm to full cervical dilation of 10 cm.&#x000a0;The second stage of labor&#x000a0;starts with cervical dilation of 10cm and ends with the delivery of the baby.&#x000a0;The third stage of labor starts when the fetus is delivered and ends with the delivery of the placenta.&#x000a0;</p>
      </sec>
      <sec id="article-36115.s6" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>
<bold>Electrophysiology of Contractions</bold>
</p>
        <p>Resting membrane potential is due to the electrochemical gradient, mainly created by the potassium ions concentrated inside the cell and, to a lesser extent, by the calcium, sodium, and chloride ions concentrated extracellularly.&#x000a0;Two types of Action Potentials have been observed in uterine myocytes: depolarization followed by rapid repolarization and the other with initial depolarization with a sustained plateau. It is the release of calcium ions from intracellular stores, as well as the influx of calcium ions from the extracellular space, that initiates the action potentials. When the membrane potential is depolarized to about &#x02212;40 mV, the L-type voltage-operated Calcium channels open, causing the influx of calcium ions.&#x000a0;T-type Ca&#x000a0;channels are also found in uterine myocytes and have a role in the propagation of action potentials.<xref ref-type="bibr" rid="article-36115.r3">[3]</xref></p>
        <p>Interaction of the uterine agonists with the GPCR located on the plasma membrane of myocyte leads to a chain of events ultimately causing the&#x000a0;IP&#x02013;IPR mediated Ca&#x000a0;release from the Sarcoplasmic Reticulum. This further elevated the concentration of calcium in the cytosol as well as the voltage of the plasma membrane. Another process causing the propagation of action potential is the positive feedback mechanism of calcium, known as the&#x000a0;&#x000a0;Ca-induced Ca&#x000a0;release (CICR), whereby increasing the intracellular concentration of calcium stimulates other Ca&#x000a0;channels to open.&#x000a0;Perhaps the Store-operated Ca entry (SOCE) pathway is the most poorly understood. When the intracellular stores of Ca&#x000a0;in the SR are emptied, a &#x02018;calcium influx factor&#x02019; (CIF)&#x000a0;is released, which causes the plasma membrane to allow the influx of extracellular Ca. Lipid rafts, termed as &#x02018;caveolae&#x02019; which are stabilized by a scaffolding protein, caveolin, present on the plasma membrane of myocytes, are also involved in signal transduction and&#x000a0;myocyte excitability.</p>
        <p>After the influx of calcium ions and their subsequent binding to calmodulin,&#x000a0;a conformational change in Myosin Light Chain Kinase leads to an increase in phosphorylation of myosin light chain at serine residue 19, which causes myosin cross-bridge to attach to the actin filament and bring about the contraction.&#x000a0;The relaxation of myocytes is brought about by the efflux of calcium ions out of the cytosol into the SR and extracellular space. Plasma membrane&#x000a0;Ca-ATPase (PMCA) and the&#x000a0;SR/ER Ca-ATPase (SERCA)&#x000a0;belong to the&#x000a0;P-type Ca-ATPases family, are responsible for moving&#x000a0;1 Ca&#x000a0;ion out of the intracellular compartment in exchange for an H+ restore the resting membrane potential.&#x000a0;Another mechanism involves the&#x000a0;Na/Ca&#x000a0;exchanger (NCX), with the virtue of the electrochemical gradient of Na&#x000a0;created by the Na/K&#x000a0;ATPase. Interestingly, calcium itself causes calcium ion clearance: Calcium ions inhibit L-type calcium channels, and the calcium-calmodulin complex also stimulates CaM-Kinase II (CaMKII), which inhibits L-type calcium channels.</p>
        <p>
<bold>Calcium Sensitization and Desensitization</bold>
</p>
        <p>The increased sensitivity of regulatory and contractile proteins to calcium, eventually resulting in stronger contraction, is known as Calcium Sensitization after stimulation with an agonist. The vice versa is true for calcium desensitization. This is established through the&#x000a0;RhoA/Rho-kinase signaling pathway. Activation of G-protein coupled receptors (GPCRs) causes the recruitment of RhoA to the plasma membrane after exchanging GDP for GTP. This activates the Rho-associated kinase (ROK), which phosphorylates the myosin targeting subunit (MYPT1) of Myosin Light Chain Phosphatase, preventing the dephosphorylation of Myosin Light Chain. The mRNAs for RhoA, ROK-1, and ROK-2 are present in the non-gravid uterus and increase during pregnancy. ROK inhibition hampers force development and promotes relaxation without altering the level of [Ca]&#x000a0;in spontaneous and agonist-stimulated contractions. Similarly,&#x000a0;cAMP causes phosphorylation of MLCK itself by a cAMP-dependent protein kinase, which decreases enzymatic activity by decreasing the affinity of the MLCK for the calmodulin-calcium complex.&#x000a0;Several receptors are found on the surface of myometrial cells that affect contractility. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Oxytocin receptors: Contractility agonist</p>
          </list-item>
          <list-item>
            <p>Estrogen receptors: Contractility agonist&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Progesterone receptors: Contractility antagonist&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Beta2&#x000a0;adrenergic receptors cause an increase in cAMP levels, hence contractility antagonist&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Alpha-adrenergic receptors cause a decrease in cAMP levels, hence contractility agonist</p>
          </list-item>
        </list>
        <p>These receptors are the targets of multiple drugs used to manage abnormal labor. The exact sequence of events that leads to uterine contractions is still largely&#x000a0;unknown. Some studies suggest mechanical stretch and hormones&#x000a0;work together to&#x000a0;initiate&#x000a0;contractions in normal labor.<xref ref-type="bibr" rid="article-36115.r2">[2]</xref>&#x000a0;However, due to the role of inflammation in preterm labor, other studies suggest that inflammatory mediators, such as cytokines and prostaglandins,&#x000a0;initiate&#x000a0;uterine contractions.<xref ref-type="bibr" rid="article-36115.r4">[4]</xref>&#x000a0;</p>
        <p>
<bold>Mechanical Stretch</bold>
</p>
        <p>Mechanical stretch refers to tension on myometrial cells as the uterus distends. The physical stretching of the uterus results in an influx of ions, namely sodium and calcium, that change the action potential across myometrial cells.<xref ref-type="bibr" rid="article-36115.r5">[5]</xref><xref ref-type="bibr" rid="article-36115.r6">[6]</xref>&#x000a0;This change facilitates the onset of uterine contractions.&#x000a0;The number of connexins (gap junctions) between myometrial cells increases before labor, allowing coordinated muscle contraction. These&#x000a0;cell-to-cell contacts are less abundant early in pregnancy, favoring uterine quiescence.<xref ref-type="bibr" rid="article-36115.r7">[7]</xref>&#x000a0;There has also been a suggestion that uterine overdistention causes an "inflammatory pulse" that further activates myometrial contractility.<xref ref-type="bibr" rid="article-36115.r8">[8]</xref></p>
        <p>
<bold>Inflammatory Mediators</bold>
</p>
        <p>Many studies suggest that inflammation is a mediator of labor.<xref ref-type="bibr" rid="article-36115.r8">[8]</xref><xref ref-type="bibr" rid="article-36115.r9">[9]</xref>&#x000a0;Inflammatory markers most notably include prostaglandins, which increase in concentration before the onset of&#x000a0;labor due to a functional progesterone withdrawal, leading to an increased estrogen-to-progesterone ratio.<xref ref-type="bibr" rid="article-36115.r10">[10]</xref>&#x000a0;The amnion and chorion produce PGE2, and the decidua produces PGE2 and PGF2.</p>
        <p>The&#x000a0;2 most studied prostaglandins involved in uterine contractions include prostaglandin E1 (PGE1) and prostaglandin E2 (PGE2.) They&#x000a0;stimulate myometrial contractility, most likely by acting as calcium ionophores, leading to an increase in intracellular calcium. Misoprostol is the synthetic version of PGE1, which, although initially designed to prevent peptic ulcers, proved to have a dose-dependent effect on myometrial contractility.<xref ref-type="bibr" rid="article-36115.r10">[10]</xref></p>
        <p>PGE2 also plays a role in uterine contractions by activating EP1 and EP3 receptors on myometrial cells.<xref ref-type="bibr" rid="article-36115.r11">[11]</xref>&#x000a0;However, the major physiological effect of PGE2 during labor is the activation of inflammatory mediators IL-8 and TNF-alpha that activate collagenases and MMPs, leading to the ripening of the cervix.<xref ref-type="bibr" rid="article-36115.r10">[10]</xref></p>
        <p>Prostaglandin F2 alpha (PGF2a) is less studied, but it is thought to decrease progesterone levels and independently increase uterine contractility by stimulating smooth muscle cells.<xref ref-type="bibr" rid="article-36115.r12">[12]</xref>&#x000a0;Prostaglandins also play a role in uterine contractions after the delivery of the fetus.&#x000a0;During this time, also known as stage 3 of labor, the placenta secretes prostaglandins that lead to its detachment from the endometrial cavity.<xref ref-type="bibr" rid="article-36115.r13">[13]</xref>&#x000a0;Contractions during this period also minimize postpartum bleeding. Lack of contractions during this period can occur due to uterine atony.</p>
        <p>
<bold>Hormones</bold>
</p>
        <p>The primary hormones involved include estrogen, progesterone, and oxytocin.&#x000a0;Oxytocin is one of the most widely studied&#x000a0;hormones&#x000a0;involved in uterine contractions. It decreases Ca2+ efflux by inhibiting the Ca2+/ATPase of the myometrial cell membrane, which pumps calcium from the inside to the extracellular space, and increases Ca2+ influx, as well as causes the release of Ca2+ from the SR via IICR. Studies suggest that the increased estrogen-to-progesterone ratio that occurs before the onset of labor leads to an increased number of oxytocin receptors in the uterus.<xref ref-type="bibr" rid="article-36115.r14">[14]</xref>&#x000a0;Many animal studies also show an increase in oxytocin concentration before labor; however, there is limited evidence regarding this phenomenon in humans due to technical difficulties in obtaining oxytocin levels in laboring women.<xref ref-type="bibr" rid="article-36115.r15">[15]</xref></p>
        <p>Oxytocin: The process starts with the hypothalamus, paraventricular and supraoptic nuclei. These nuclei generate and secrete oxytocin, the major contributor being the paraventricular nucleus.&#x000a0;Oxytocin then travels to the posterior pituitary via the&#x000a0;hypothalamic-hypophysial tract. After oxytocin arrives in the posterior pituitary, it accesses the systemic blood supply, which delivers the oxytocin molecule to oxytocin receptors on myometrial cells. The uterine epithelial lining also makes oxytocin during pregnancy, acting in an autocrine and paracrine fashion.<xref ref-type="bibr" rid="article-36115.r16">[16]</xref><xref ref-type="bibr" rid="article-36115.r17">[17]</xref>&#x000a0;The positive feedback mechanism of oxytocin further catalyzes the onset of labor.<xref ref-type="bibr" rid="article-36115.r15">[15]</xref><xref ref-type="bibr" rid="article-36115.r18">[18]</xref><xref ref-type="bibr" rid="article-36115.r19">[19]</xref>. These receptors are rhodopsin class 1 G proteins that couple with phospholipase C (PLC), which then activates inositol triphosphate (IP3) and diacylglycerol (DAG). Activated IP3 mobilizes calcium from the sarcoplasmic reticulum, which binds to myosin light chain kinases, resulting in smooth muscle contraction.<xref ref-type="bibr" rid="article-36115.r15">[15]</xref></p>
        <p>Progesterone: It decreases permeability for calcium, sodium, and potassium, as well as modulates the intracellular calcium-binding that makes less calcium available for the calmodulin-MLCK system by increasing the rate of cAMP synthesis. It is vital for the maintenance of pregnancy as it causes uterine relaxation during early pregnancy, and its functional withdrawal leads to an increased estrogen-to-progesterone ratio that causes an increase in prostaglandin concentration, triggering labor.<xref ref-type="bibr" rid="article-36115.r20">[20]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-36115.s7" sec-type="Related Testing">
        <title>Related Testing</title>
        <p>External tocometers and intrauterine pressure catheters are the primary clinical methods of monitoring myometrial activity. Although both devices allow visualization of contractions relative to the fetal heart rate, only intrauterine pressure catheters enable precise measurement of the strength of uterine contractions. There should be&#x000a0;3 to 5 contractions in the 10-minute window, each lasting 30 to 40 seconds. The monitoring of uterine contractions should be continuous during labor.</p>
        <p>
<bold>External Tocometer</bold>
</p>
        <p>Two probes are placed on the woman&#x02019;s abdomen,&#x000a0;1 over the uterine fundus and the other in proximity to the fetal heart. This approach is the standard method of monitoring uterine contractions in laboring women.&#x000a0;</p>
        <p>
<bold>Intrauterine Pressure Catheter</bold>
</p>
        <p>A thin catheter is inserted into the uterus and monitors changes in pressure. The standard unit of measurement is the Montevideo unit (MVU). Adequate contractions are defined as a total of 200 MVU within 10 minutes.&#x000a0;Internal monitoring has limited use because it requires the rupture of fetal membranes for placement. It is commonly used with a fetal scalp electrode that monitors fetal heart rate.</p>
      </sec>
      <sec id="article-36115.s8" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Chorioamnionitis is an acute inflammation of the membranes and chorion of the placenta, typically due to ascending polymicrobial bacterial infection in the setting of membrane rupture.<xref ref-type="bibr" rid="article-36115.r21">[21]</xref> It is associated with an elevation in prostaglandin levels. As PG stimulates myometrial contractility and softening of the cervix, it leads to the induction of preterm labor.<xref ref-type="bibr" rid="article-36115.r22">[22]</xref></p>
        <p>Protracted stages of labor indicate that cervical change is occurring at a slower pace than expected in the presence or absence of adequate contractions. Arrest means complete cessation of labor's progress. It can be elaborated as the absence of cervical change for more than 4 hours in the presence of adequate contractions or the absence of cervical change for more than 6 hours in the presence of inadequate contractions. Abnormal third-stage labor is placenta retention for more than 30 minutes.</p>
      </sec>
      <sec id="article-36115.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Understanding the physiology of uterine contractions allows clinicians to use targeted therapy for both the induction and cessation of labor. Commonly used medications for induction of labor include oxytocin, misoprostol, and&#x000a0;dinoprostone. Because&#x000a0;uterine contractions dually function to minimize postpartum bleeding, these&#x000a0;are the same&#x000a0;medications used to manage postpartum hemorrhage. Carboprost, an analog of PGF2a, is an additional medication used to manage postpartum hemorrhage, not used for the induction of labor.</p>
        <p>Oxytocin is commonly used in modern obstetric practice to increase contractions when&#x000a0;the labor process has failed to promote vaginal delivery.<xref ref-type="bibr" rid="article-36115.r23">[23]</xref>&#x000a0;Prostaglandins are active contractile agents, and their analogs are combined with mifepristone (an antiprogestin)for uterine evacuation during early and second-trimester pregnancy.[24][25][24] Misoprostol is cheaper than gemeprost and does not need refrigeration,&#x000a0;so it is the prostaglandin of choice.</p>
        <p>In 2013, the FDA approved the use of progesterone supplementation (hydroxyprogesterone caproate) during pregnancy to reduce the risk of recurrent preterm birth in women with a history of at least&#x000a0;1 prior spontaneous preterm delivery.<xref ref-type="bibr" rid="article-36115.r24">[24]</xref>&#x000a0;It is&#x000a0;protective against recurrent preterm birth as&#x000a0;the rate of recurrent preterm birth with its use decreases to 25% to 31% compared with 33% to 47% in placebo controls.<xref ref-type="bibr" rid="article-36115.r25">[25]</xref></p>
        <p>Medications used to stop preterm labor antagonize uterine contractions. Commonly used tocolytics include nifedipine, terbutaline, magnesium&#x000a0;sulfate, indomethacin, and atosiban. Figure 1 summarizes&#x000a0;the medications used for induction of labor and tocolysis. Of these tocolytic agents, beta sympathomimetics, oxytocin receptor antagonists, and calcium channel blockers have the most promising data regarding efficacy.<xref ref-type="bibr" rid="article-36115.r26">[26]</xref>&#x000a0;Magnesium sulfate is a weak tocolytic but not used for tocolysis. It is administered to lower the risk of neurologic comorbidities in babies born at &#x0003c;32 weeks gestation. There is evidence that NSAIDs and CCBs are&#x000a0;better than magnesium and beta sympathomimetics in terms of neonatal and maternal outcomes and maternal complications.<xref ref-type="bibr" rid="article-36115.r27">[27]</xref>&#x000a0;However, NSAIDs may lead to side effects such as&#x000a0;oligohydramnios, renal failure, necrotizing enterocolitis, intraventricular hemorrhage, and closure of the patent ductus arteriosus.<xref ref-type="bibr" rid="article-36115.r28">[28]</xref> Hence, calcium channel blockers are the drug of choice for tocolysis beyond 32 weeks gestation. CCBs can lead to maternal hypotension and tachycardia. Tocolytics are not recommended beyond 34 weeks gestation&#x000a0;as their risks&#x000a0;outweigh the risks of premature delivery.</p>
        <p>Understanding the&#x000a0;normal pattern of contractions is also useful in defining the arrest of labor, which has different management based on the stage. For example, an arrested latent phase is an indication of augmentation with oxytocin, while an arrested active phase is an indication of the cesarean section. Defining the true arrest of labor requires analysis of the adequacy of uterine contractions, which requires the use of an intrauterine pressure catheter. Active phase arrest has specific requirements, which include&#x000a0;4 or more hours of adequate contractions or&#x000a0;6 or more hours of inadequate contractions. These definitions are essential for clinicians because they dictate management algorithms.</p>
      </sec>
      <sec id="article-36115.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36115&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36115">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36115/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36115">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-36115.s11">
        <fig id="article-36115.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Medications Used to Manage Abnormal Labor. The table summarizes medications that are used to manage abnormal labor. Contributed by A McEvoy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Abnormal__Labor__Table" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-36115.s12">
        <title>References</title>
        <ref id="article-36115.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Preller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manstein</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Myosin structure, allostery, and mechano-chemistry.</article-title>
            <source>Structure</source>
            <year>2013</year>
            <month>Nov</month>
            <day>05</day>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>1911</fpage>
            <page-range>1911-22</page-range>
            <pub-id pub-id-type="pmid">24210227</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garfield</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Maner</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Physiology and electrical activity of uterine contractions.</article-title>
            <source>Semin Cell Dev Biol</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>289</fpage>
            <page-range>289-95</page-range>
            <pub-id pub-id-type="pmid">17659954</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohkubo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawarabayashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Identification and electrophysiological characteristics of isoforms of T-type calcium channel Ca(v)3.2 expressed in pregnant human uterus.</article-title>
            <source>Cell Physiol Biochem</source>
            <year>2005</year>
            <volume>16</volume>
            <issue>4-6</issue>
            <fpage>245</fpage>
            <page-range>245-54</page-range>
            <pub-id pub-id-type="pmid">16301824</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ravanos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dagklis</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Petousis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Margioula-Siarkou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Prapas</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Prapas</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Factors implicated in the initiation of human parturition in term and preterm labor: a review.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2015</year>
            <volume>31</volume>
            <issue>9</issue>
            <fpage>679</fpage>
            <page-range>679-83</page-range>
            <pub-id pub-id-type="pmid">26303116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kao</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>McCullough</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Ionic currents in the uterine smooth muscle.</article-title>
            <source>J Physiol</source>
            <year>1975</year>
            <month>Mar</month>
            <volume>246</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-36</page-range>
            <pub-id pub-id-type="pmid">1133781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wray</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burdyga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Noble</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Borysova</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arrowsmith</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Progress in understanding electro-mechanical signalling in the myometrium.</article-title>
            <source>Acta Physiol (Oxf)</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>213</volume>
            <issue>2</issue>
            <fpage>417</fpage>
            <page-range>417-31</page-range>
            <pub-id pub-id-type="pmid">25439280</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lefebvre</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Piersanti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bai</surname>
                <given-names>XH</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ZQ</given-names>
              </name>
              <name>
                <surname>Lye</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Myometrial transcriptional regulation of the gap junction gene, connexin-43.</article-title>
            <source>Reprod Fertil Dev</source>
            <year>1995</year>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>603</fpage>
            <page-range>603-11</page-range>
            <pub-id pub-id-type="pmid">8606973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams Waldorf</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Ngo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bansal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paolella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Herbert</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Sooranna</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Gough</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Astley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Baldessari</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Bammler</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>MacDonald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gravett</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Rajagopal</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>213</volume>
            <issue>6</issue>
            <fpage>830.e1</fpage>
            <page-range>830.e1-830.e19</page-range>
            <pub-id pub-id-type="pmid">26284599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Lockwood</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Norwitz</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Role of cytokines in preterm labor and birth.</article-title>
            <source>Minerva Ginecol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-66</page-range>
            <pub-id pub-id-type="pmid">16170281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bakker</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The role of prostaglandins E1 and E2, dinoprostone, and misoprostol in cervical ripening and the induction of labor: a mechanistic approach.</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>296</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-179</page-range>
            <pub-id pub-id-type="pmid">28585102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandola</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Sykes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Hanyaloglu</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>EP2 receptor activates dual G protein signaling pathways that mediate contrasting proinflammatory and relaxatory responses in term pregnant human myometrium.</article-title>
            <source>Endocrinology</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>155</volume>
            <issue>2</issue>
            <fpage>605</fpage>
            <page-range>605-17</page-range>
            <pub-id pub-id-type="pmid">24265450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Rensis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Saleri</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tummaruk</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Techakumphu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirkwood</surname>
                <given-names>RN</given-names>
              </name>
            </person-group>
            <article-title>Prostaglandin F2&#x003b1; and control of reproduction in female swine: a review.</article-title>
            <source>Theriogenology</source>
            <year>2012</year>
            <month>Jan</month>
            <day>01</day>
            <volume>77</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-11</page-range>
            <pub-id pub-id-type="pmid">21958632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husslein</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>[The importance of oxytocin and prostaglandins to the mechanism of labor in humans].</article-title>
            <source>Wien Klin Wochenschr Suppl</source>
            <year>1984</year>
            <volume>155</volume>
            <fpage>1</fpage>
            <page-range>1-32</page-range>
            <pub-id pub-id-type="pmid">6099005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilicic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zakar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>The expression of genes involved in myometrial contractility changes during ex situ culture of pregnant human uterine smooth muscle tissue.</article-title>
            <source>J Smooth Muscle Res</source>
            <year>2017</year>
            <volume>53</volume>
            <issue>0</issue>
            <fpage>73</fpage>
            <page-range>73-89</page-range>
            <pub-id pub-id-type="pmid">28652518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arrowsmith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wray</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Oxytocin: its mechanism of action and receptor signalling in the myometrium.</article-title>
            <source>J Neuroendocrinol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>356</fpage>
            <page-range>356-69</page-range>
            <pub-id pub-id-type="pmid">24888645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Voltolini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Petraglia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Neuroendocrinology of pregnancy and parturition.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2014</year>
            <volume>124</volume>
            <fpage>17</fpage>
            <page-range>17-36</page-range>
            <pub-id pub-id-type="pmid">25248577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iliodromiti</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Antonakopoulos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sifakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsikouras</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Daniilidis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dafopoulos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Botsis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vrachnis</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Endocrine, paracrine, and autocrine placental mediators in labor.</article-title>
            <source>Hormones (Athens)</source>
            <year>2012</year>
            <season>Oct-Dec</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-409</page-range>
            <pub-id pub-id-type="pmid">23422762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Findlay</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>The control of parturition.</article-title>
            <source>Res Reprod</source>
            <year>1972</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>5</issue>
            <fpage>Chart</fpage>
            <pub-id pub-id-type="pmid">12333036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neumann</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Pittman</surname>
                <given-names>QJ</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Landgraf</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition-related events.</article-title>
            <source>J Neuroendocrinol</source>
            <year>1996</year>
            <month>Mar</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">8730656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nadeem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shynlova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Matysiak-Zablocki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mesiano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lye</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Molecular evidence of functional progesterone withdrawal in human myometrium.</article-title>
            <source>Nat Commun</source>
            <year>2016</year>
            <month>May</month>
            <day>25</day>
            <volume>7</volume>
            <fpage>11565</fpage>
            <pub-id pub-id-type="pmid">27220952</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tita</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>WW</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of clinical chorioamnionitis.</article-title>
            <source>Clin Perinatol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>339</fpage>
            <page-range>339-54</page-range>
            <pub-id pub-id-type="pmid">20569811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van der Elst</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>L&#x000f2;pez Bernal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sinclair-Smith</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>The role of chorioamnionitis and prostaglandins in preterm labor.</article-title>
            <source>Obstet Gynecol</source>
            <year>1991</year>
            <month>May</month>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>672</fpage>
            <page-range>672-6</page-range>
            <pub-id pub-id-type="pmid">1849624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clark</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Knox</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Garite</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Oxytocin: new perspectives on an old drug.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>200</volume>
            <issue>1</issue>
            <fpage>35.e1</fpage>
            <page-range>35.e1-6</page-range>
            <pub-id pub-id-type="pmid">18667171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norwitz</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Caughey</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Progesterone supplementation and the prevention of preterm birth.</article-title>
            <source>Rev Obstet Gynecol</source>
            <year>2011</year>
            <season>Summer</season>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>60</fpage>
            <page-range>60-72</page-range>
            <pub-id pub-id-type="pmid">22102929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez-Ramos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kaunitz</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Delke</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.</article-title>
            <source>Obstet Gynecol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>105</volume>
            <issue>2</issue>
            <fpage>273</fpage>
            <page-range>273-9</page-range>
            <pub-id pub-id-type="pmid">15684151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000f6;sli</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sperschneider</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Drack</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Surbek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Irion</surname>
                <given-names>O</given-names>
              </name>
              <collab>Swiss Society of Obstetrics and Gynecology</collab>
            </person-group>
            <article-title>Tocolysis for preterm labor: expert opinion.</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>289</volume>
            <issue>4</issue>
            <fpage>903</fpage>
            <page-range>903-9</page-range>
            <pub-id pub-id-type="pmid">24385286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hanley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sayres</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Reiff</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grotegut</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kuller</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Tocolysis: A Review of the Literature.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>50</fpage>
            <page-range>50-55</page-range>
            <pub-id pub-id-type="pmid">30648727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36115.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abou-Ghannam</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Usta</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Nassar</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Indomethacin in pregnancy: applications and safety.</article-title>
            <source>Am J Perinatol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>175</fpage>
            <page-range>175-86</page-range>
            <pub-id pub-id-type="pmid">21786219</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
